UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 11,863 Shares of National Research Co. (NASDAQ:NRC)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lowered its holdings in shares of National Research Co. (NASDAQ:NRC) by 24.1% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 37,417 shares of the company’s stock after selling 11,863 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.16% of National Research worth $855,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in NRC. CWM LLC grew its holdings in National Research by 889.7% during the second quarter. CWM LLC now owns 1,158 shares of the company’s stock valued at $27,000 after purchasing an additional 1,041 shares during the period. Quarry LP purchased a new position in shares of National Research during the 2nd quarter valued at about $54,000. Benjamin F. Edwards & Company Inc. grew its stake in shares of National Research by 145.6% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 2,783 shares of the company’s stock valued at $64,000 after acquiring an additional 1,650 shares during the period. FMR LLC increased its holdings in National Research by 397.3% in the 3rd quarter. FMR LLC now owns 2,944 shares of the company’s stock worth $67,000 after acquiring an additional 2,352 shares in the last quarter. Finally, Gladius Capital Management LP raised its stake in National Research by 164.5% during the 3rd quarter. Gladius Capital Management LP now owns 3,068 shares of the company’s stock worth $70,000 after acquiring an additional 1,908 shares during the period. Hedge funds and other institutional investors own 47.26% of the company’s stock.

National Research Stock Performance

NRC opened at $17.07 on Friday. The company has a 50 day simple moving average of $19.04 and a two-hundred day simple moving average of $21.61. The company has a debt-to-equity ratio of 1.30, a current ratio of 0.47 and a quick ratio of 0.47. The firm has a market cap of $400.80 million, a P/E ratio of 15.11 and a beta of 0.52. National Research Co. has a 1-year low of $16.74 and a 1-year high of $42.18.

National Research (NASDAQ:NRC) last issued its earnings results on Friday, October 25th. The company reported $0.24 earnings per share for the quarter. National Research had a net margin of 18.78% and a return on equity of 67.40%. The company had revenue of $35.82 million during the quarter.

National Research Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 10th. Shareholders of record on Friday, December 27th will be issued a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 2.81%. The ex-dividend date is Friday, December 27th. National Research’s dividend payout ratio (DPR) is currently 42.48%.

National Research Company Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.